A Cycloadditive Route to Enantiomerically Pure Amino Fluoro Alcohols
20.1 Hz, 1 F, CH2F). Ϫ Selected NOEs (CDCl3): {3-H} enhanced (Q, 2 Me), 47.83 (D, C-3), 57.07 (Dd, JC,F ϭ 5.5 Hz, C-4), 62.10
FULL PAPER
3
2
4-H (2%), 5-H (1%), 2-CH2 (2%), 1Ј-OCH2 (0.5%) and 1Ј-CH2 (T, 2 OCH2), 70.90 (D, C-2), 71.76 (Dd, JC,F ϭ 19.0 Hz, C-5),
(1%); {4-H} enhanced 3-H (2%), 5-H (2.5%), 1Ј-H (2.5%), 1Ј-OCH2 85.44 (Td, 1JC,F ϭ 170.0 Hz, C-6), 172.11 and 177.52 (S, 2 CO). Ϫ
(1%) and 1Ј-CH2 (0.5%); {5-H} enhanced 3-H (0.5%), 4-H (2%), 19F NMR (CD3OD): δ ϭ Ϫ230.75 (dt, J ϭ 21.5 and 47.3 Hz,
and 2-CH2 (1.5%); {1Ј-H} enhanced 4-H (3%), 2-CH2 (0.5%), 1Ј-
CH2F). Ϫ IR (KBr): ν˜ ϭ 3451 cmϪ1, 3341 (νOH, νNH), 1708 (νCOO).
OCH2 (2%) and 1Ј-CH2 (1%); {2-CH2} enhanced 3-H (10.5%), 5- Ϫ MS (FAB/Xe); m/z (%): 282 (25) [M ϩ H]ϩ, 244 (20)
H (9%) and 1Ј-H (2%); {1Ј-OCH2} enhanced 3-H (0.5%), 4-H [C11H18NO5]ϩ, 236 (85) [C9H15FNO5]ϩ, 218 (63) [C9H13FNO4]ϩ,
(0.5%) and 1Ј-H (2%); {F} enhanced 3-H (1.5%), 1Ј-H (2.5%), 1Ј-
190 (45) [C8H12O5]ϩ·, 172 (78) [C7H12O4]ϩ·, 91 (100) [C3H6FNO]ϩ·
Ϫ C11H20FNO6 (281.28): calcd. C 46.97, H 7.17, N 4.98; found C
.
OCH2 (0.5%) and 1Ј-CH2 (7.5%). Ϫ IR (film): ν˜ ϭ 2984 cmϪ1
,
1735, 1455, 1372, 1218, 1097, 1030, 754, 699. Ϫ MS (EI): 460 (5) 46.84, H 7.06, N 5.07.
[M ϩ H]ϩ, 386 (1) [C22H25FNO4]ϩ, 307 (7) [C16H21NO5]ϩ·, 306
(2R,3R,4S,5R)-7 (Minor): [α]D20 ϭ ϩ25.6 (c ϭ 0.1, CH3OH). Ϫ 1H
(40) [C16H20NO5]ϩ, 280 (10) [C14H15FNO4]ϩ, 260 (37)
[C11H15FNO5]ϩ, 164 (10) [C9H7FNO]ϩ, 91 (100) [C7H7]ϩ·. Ϫ
C25H30FNO6 (459.51): calcd. C 65.35, H 6.58, N 3.05; found C
65.47, H 6.50, N 3.13.
NMR (CD3OD ϩ D2O): δ ϭ 1.28 (t, J ϭ 7.2 Hz, 6 H, 2 Me), 3.39
(dd, J ϭ 8.3 and 3.9 Hz, 1 H, 3-H), 3.79 (ddt, J ϭ 15.3, 3.6, and
5.8 Hz, 1 H, 5-H), 4.01 (dd, J ϭ 3.9 and 3.6 Hz, 1 H, 4-H), 4.17
and 4.18 (q, J ϭ 7.2 Hz, 4 H, 2 CH2), 4.38 (dd, J ϭ 47.1 and
5.8 Hz, 2 H, CH2F), 4.54 (d, J ϭ 8.3 Hz, 1 H, 2-H). Ϫ 13C NMR
(CD3OD): δ ϭ 14.53 (Q, 2 Me), 50.18 (D, C-3), 56.97 (Dd, 3JC,F ϭ
5.5 Hz, C-H), 62.11 (T, 2 OCH2), 70.87 (D, C-2), 71.85 (Dd,
(3S,4R,5R,1ЈR)-6 (Minor): Rf ϭ 0.33. Ϫ 1H NMR (CDCl3/[D6]ben-
zene, 1:2): δ ϭ 1.28 (t, J ϭ 7.1 Hz, 6 H, 2 OCH2Me), 3.66 (dddd,
J ϭ 20.2, 6.7, 5.4, and 3.6 Hz, 1 H, 1Ј-H), 3.68 (ddd, J ϭ 6.7, 4.7,
and 1.2 Hz, 1 H, 3-H), 3.77 (dd, J ϭ 5.7 and 4.7 Hz, 1 H, 4-H),
4.12 and 4.15 (br. d, J ϭ 13.5 Hz, 2 H, NCH2), 4.21 and 4.23 (q,
J ϭ 7.1 Hz, 4 H, 2 OCH2Me), 4.55 (ddd, J ϭ 47.1, 10.5, and
5.4 Hz, 1 H, CHaF), 4.56 (ddd, J ϭ 47.3, 10.5, and 3.6 Hz, 1 H,
CHbF), 4.60 and 4.63 (br. d, J ϭ 11.7 Hz, 2 H, OCH2), 4.99 (d,
J ϭ 5.7 Hz, 1 H, 5-H), 7.2Ϫ7.4 (m, 10 H, ArH). Ϫ 13C NMR
(CDCl3) δ ϭ 14.09 and 14.21 (Q, 2 OCH2Me); 53.18 (D, C-4);
61.30 (T, NCH2), 61.78 and 61.86 (T, 2 OCH2Me); 68.19 (Dd,
3JC,F ϭ 6.9 Hz, C-3); 72.95 (T, OCH2); 78.29 (Dd, 2JC,F ϭ 18.5 Hz,
1
2JC,F ϭ 19.8 Hz, C-5), 85.16 (Td, JC,F ϭ 170.6 Hz, C-6), 171.93
and 177.90 (S, 2 CO). Ϫ 19F NMR (CD3OD) δ ϭ Ϫ227.68 (dt,
J ϭ 15.3 and 47.1 Hz, CH2F). Ϫ MS (FAB/Xe); m/z (%): 282 (55)
[M ϩ H]ϩ, 244 (48) [C11H18NO5]ϩ, 236 (82) [C9H15FNO5]ϩ, 198
(42) [C9H12NO4]ϩ, 190 (45) [C8H12O5]ϩ·, 170 (100) [C7H10O4]ϩ·, 91
(78) [C3H6FNO]ϩ·. Ϫ C11H20FNO6 (281.20): calcd. C 46.97, H
7.17, N 4.98; found C 47.09, H 7.08, N 4.86.
Reaction of Nitrone (R)-5 with Dimethylacetylene Dicarboxylate:
Neat dimethylacetylene dicarboxylate (61 µL, 0.5 mmol) was added
by syringe to a solution of nitrone (R)-5 (120 mg, 0.4 mmol) in
CCl4 (8.5 mL) under nitrogen. The reaction mixture was stirred at
40°C for 6 h. The solvent was evaporated to dryness and the resi-
due was purified by flash chromatography with an n-hexane/ethyl
acetate (4:1) mixture as eluant to give 2,3-dihydroisoxazoles (3R/
S,1ЈR)-8 as the only detectable 2:1 epimeric mixture of compounds:
129 mg (76% yield); Rf ϭ 0.35.
1
C-1Ј); 78.70 (D, C-5); 83.53 (Td, JC,F ϭ 171.0 Hz, CH2F); 127.45
(D), 127.67 (D), 127.83 (D), 128.26 (D), 128.34 (D), 128.84 (D),
136.48 (S), and 137.73 (S) (ArC); 169.43 and 171.80 (S, 2 CO2Et).
Ϫ
19F NMR (CDCl3): δ ϭ Ϫ230.45 (br. ddd, J ϭ 47.3, 47.1, and
20.2 Hz, 1 F, CH2F). Ϫ Selected NOEs (CDCl3/[D6]benzene, 1:2):
{3-H} enhanced 4-H (1%), 5-H (1%), 1Ј-H (2%), 2-CH2 (2%), 1Ј-
OCH2 (1%) and 1Ј-CH2 (1%); {4-H} enhanced 3-H (1%), 5-H (2%),
1Ј-H (3%), 1Ј-OCH2 (0.5%) and 1Ј-CH2 (1.5%); {5-H} enhanced
3-H (1%), 4-H (2.5%) and 2-CH2 (1.5%); {1Ј-H} enhanced 3-H
(1%), 4-H (2.5%), 1Ј-OCH2 (2%) and 1Ј-CH2 (1.5%); {2-CH2} en-
hanced 3-H (11%) and 5-H (11.5%); {1Ј-OCH2} enhanced 3-H
(2%) and 1Ј-H(3%); {1Ј-CH2} enhanced 4-H (3.5%) and 1Ј-H (3%);
{F} enhanced 3-H (3%), 4-H (3.5%), 1Ј-H (6%), 1Ј-OCH2 (1.5%)
and 1Ј-CH2 (10.5%). Ϫ IR (film): ν˜ ϭ 2928.21 cmϪ1, 2365, 1734
(νCOO), 1456, 1374, 1265, 1218, 1098, 1029, 757. Ϫ MS (EI); m/z
(%): 460 (5) [M ϩ H]ϩ, 386 (20) [C22H25FNO4]ϩ, 306 (20)
[C16H20NO5]ϩ, 280 (5) [C14H15FNO4]ϩ, 260 (20) [C11H15FNO5]ϩ,
165 (8) [C9H8FNO]ϩ·, 91 (100) [C7H7]ϩ·. Ϫ C25H30FNO6 (459.51):
calcd. C 65.35, H 6.58, N 3.05; found C 65.27, H 6.66, N 3.15.
1
(3R,1ЈR)-8 (Major): H NMR (CDCl3): δ ϭ 3.64 and 3.88 (s, 6 H,
2 OMe), 3.85 (ddt, J ϭ 19.0, 4.8, and 4.5 Hz, 1 H, 1Ј-H), 3.94 and
4.27 (br. d, J ϭ 12.9 Hz, 2 H, NCH2), 4.47 (dd, J ϭ 4.8 and 1.3 Hz,
1 H, 3-H), 4.48 and 4.61 (br. d, J ϭ 11.7 Hz, 2 H, OCH2), 4.55
(dd, J ϭ 47.5 and 4.5 Hz, 2 H, CH2F), 7.1Ϫ7.5 (m, 10 H, ArH).
Ϫ
13C NMR (CDCl3): δ ϭ 51.96 and 53.23 (Q, 2 OMe); 63.58 (T,
3
NCH2); 69.29 (Dd, JC,F ϭ 9.2 Hz, C-3); 72.66 (T, OCH2); 79.16
2
1
(Dd, JC,F ϭ 18.5 Hz, C-1Ј); 82.92 (Td, JC,F ϭ 170.2 Hz, CH2F);
106.95 (S, C-4); 127.86 (D), 128.27 (D), 128.39 (D), 128.46 (D),
128.60 (D), 129.63 (D), 134.33 (S) and 137.74 (S) (ArC); 152.02 (S,
C-5); 159.06 and 162.62 (S, 2 CO2Me). Ϫ 19F NMR (CDCl3): δ ϭ
Ϫ231.35 (br. dt, J ϭ 19.0 and 47.5 Hz, 1 F, CH2F). Ϫ MS (EI);
m/z (%): 430 (1) [M ϩ H]ϩ, 410 (2) [C23H24NO6]ϩ, 409 (4)
Catalytic Hydrogenation of Isoxazolidines 6: A solution of the 5.5:1
mixture of isoxazolidines 6 (95 mg, 0.21 mmol) in ethyl acetate (8
mL) was hydrogenated at atmospheric pressure and at 50°C for
30 min in the presence of 20% Pd(OH)2/C (30 mg). The catalyst
was removed by filtration through a Celite pad, and the solvent
was removed under reduced pressure. The residue was flash-chro-
matographed on a silica gel column with a toluene/EtOH (4:1) mix-
ture as eluant, affording amino diols 7 (58% yield).
[C23H23NO6]ϩ·, 370 (1) [C21H21FNO4]ϩ, 353 (4) [C17H20FNO6]ϩ·
276 (8) [C14H14NO5]ϩ, 218 (5) [C12H12NO3]ϩ, 185 (18)
[C7H7NO5]ϩ· 156 (6) [C5H2NO5]ϩ, 91 (100) [C7H7]ϩ·
. Ϫ
,
,
C23H24FNO6 (429.45): calcd. C 64.33, H 5.63, N 3.26; found C
64.43, H 5.55, N 3.18.
1
(3S,1ЈR)-8 (Minor): H NMR (CDCl3): δ ϭ 3.62 and 3.91 (s, 6 H,
2 OMe), 3.88 and 4.32 (br. d, J ϭ 12.6 Hz, 2 H, NCH2), 3.90 (dddd,
J ϭ 12.0, 6.5, 5.5, and 2.5 Hz, 1 H, 1Ј-H), 4.12 (ddd, J ϭ 46.7, 9.6,
20
(2S,3S,4R,5R)-7 (Major): [α]D ϭ Ϫ54.3 (c ϭ 0.2, CH3OH). Ϫ
M.p. 112Ϫ113°C (CHCl3/AcOEt, 9:1). Ϫ 1H NMR (CD3OD ϩ and 5.5 Hz, 1 H, CHaF), 4.30 (br. d, J ϭ 2.5 Hz, 1 H, 3-H), 4.39
D2O): δ ϭ 1.27 (t, J ϭ 7.2 Hz, 6 H, 2 Me), 3.50 (dd, J ϭ 8.6 and
3.7 Hz, 1 H, 3-H), 3.78 (dddd, J ϭ 21.5, 5.1, 4.4, and 4.1 Hz, 1 H, J ϭ 11.9 Hz, 2 H, OCH2), 7.1Ϫ7.5 (m, 10 H, ArH). Ϫ 13C NMR
5-H), 3.99 (dd, J ϭ 4.4 and 3.7 Hz, 1 H, 4-H), 4.17 and 4.18 (q, (CDCl3): δ ϭ 51.64 and 52.93 (Q, 2 OMe); 63.66 (T, NCH2); 68.72
J ϭ 7.2 Hz, 4 H, 2 OCH2), 4.39 (ddd, J ϭ 47.3, 10.0, and 4.1 Hz, (Dd, JC,F ϭ 7.5 Hz, C-3); 73.60 (T, OCH2); 75.66 (Dd, JC,F
(ddd, J ϭ 47.2, 9.6, and 6.5 Hz, 1 H, CHbF), 4.53 and 4.66 (br. d,
3
2
ϭ
1
1 H, CHHF), 4.41 (ddd, J ϭ 47.3, 10.0, and 5.1 Hz, 1 H, CHHF), 18.5 Hz, C-1Ј); 82.92 (Td, JC,F ϭ 170.2 Hz, CH2F); 104.22 (S, C-
4.52 (d, J ϭ 8.6 Hz, 1 H, 2-H). Ϫ 13C NMR (CD3OD) δ ϭ 14.53 4); 127.72 (D), 128.27 (D), 128.39 (D), 128.48 (D), 128.60 (D),
Eur. J. Org. Chem. 1999, 1665Ϫ1670
1669